Lv5
1130 积分 2025-09-19 加入
Caffeine as a Viscosity-Reducing Agent for High-Concentration mAb Formulations: Insights from Molecular Dynamics Simulations
7天前
已完结
Preclinical Pharmacokinetic Study on Caffeine as an Excipient for Monoclonal Antibody Formulations
7天前
已关闭
Caffeine as a Viscosity Reducer for Highly Concentrated Monoclonal Antibody Solutions
7天前
已完结
HP-β-CD for the formulation of IgG and Ig-based biotherapeutics
8天前
已完结
Identification and Root Cause Analysis of the Visible Particles Commonly Encountered in the Biopharmaceutical Industry
9天前
已完结
Investigation on the Combined Effect of Hydroxypropyl Beta-Cyclodextrin (HPβCD) and Polysorbate in Monoclonal Antibody Formulation
9天前
已完结
Polysorbates versus Hydroxypropyl Beta-Cyclodextrin (HPβCD): Comparative Study on Excipient Stability and Stabilization Benefits on Monoclonal Antibodies
9天前
已完结
Development of high concentration protein biopharmaceuticals: The use of platform approaches in formulation development
1个月前
已完结
A new roadmap for biopharmaceutical drug product development: Integrating development, validation, and quality by design
5个月前
已完结
Insights from a Survey of Drug Formulation Experts: Challenges and Preferences in High-Concentration Subcutaneous Biologic Drug Development
5个月前
已完结
皖公网安备34019202002308
